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Small nucleolar RNAs (snoRNAs) guide chemical modifica-
tions of ribosomal and small nuclear RNAs, functions that are
carried out in thenucleus.Althoughmost snoRNAs reside in the
nucleolus, a growing body of evidence indicates that snoRNAs
are also present in the cytoplasm and that snoRNAs move
between the nucleus and cytoplasm by a mechanism that is reg-
ulated by lipotoxic and oxidative stress. Here, in a genome-wide
shRNA-based screen, we identified nuclear export factor 3
(NXF3) as a transporter that alters the nucleocytoplasmic distri-
bution of box C/D snoRNAs from the ribosomal protein L13a
(Rpl13a) locus. Using RNA-sequencing analysis, we show that
NXF3 associates not only with Rpl13a snoRNAs, but also with a
broad range of box C/D and box H/ACA snoRNAs. Under
homeostatic conditions, gain- or loss-of-function of NXF3, but
not related family member NXF1, decreases or increases cyto-
solic Rpl13a snoRNAs, respectively. Furthermore, treatment
with the adenylyl cyclase activator forskolin diminishes cytoso-
lic localization of the Rpl13a snoRNAs through a mechanism
that is dependent on NXF3 but not NXF1. Our results provide
evidence of a new role for NXF3 in regulating the distribution of
snoRNAs between the nuclear and cytoplasmic compartments.
Small nucleolar RNAs (snoRNAs)2 are a class of non-coding
RNAs that range from 60 to 250 nucleotides in length. Inmam-
malian cells, the majority of snoRNAs are encoded within
introns and processed from lariats during splicing. snoRNAs
assemble into small nucleolar ribonucleoprotein (snoRNP)
complexes with RNA-modifying enzymes and traffic to the
nucleolus, where their canonical function is to guide site-
specific nucleotide modifications of rRNA and snRNA. Two
classes of snoRNAs are defined by conserved sequence motifs,
associated proteins, and snoRNA-directed modifications. Box
C/D snoRNAs complex with fibrillarin and guide 2-O-methyl-
ation of targets, whereas box H/ACA snoRNAs complex with
dyskerin and guide pseudouridylation of targets (1–3). In addi-
tion to these canonical roles, there is growing evidence for
non-canonical molecular functions of snoRNAs, including
miRNA-like post-transcriptional regulation, pseudouridyla-
tion of mRNA targets, modification of pre-mRNAs to direct
splicing, and regulation of RNA editing (4–7).
Our laboratory previously identified that box C/D snoRNAs
encoded within the introns of the ribosomal protein L13a
(Rpl13a) gene are critical mediators of the cellular response to
palmitate-induced lipotoxic stress and play a physiological role
in tissue responses to oxidative stress (8–10). Although Rpl13a
snoRNAs localize primarily in the nucleus, these and other
snoRNAs are readily detected in the cytoplasm under homeo-
static conditions (11, 12), and they accumulate outside the
nucleus during lipotoxic conditions, oxidative stress, and serum
starvation (8, 10, 13). In addition to the pathways for nuclear
export of snoRNAs implicated by these findings, studies in
Xenopus oocytes provide evidence for an endogenous pathway
that transports snoRNAs from the cytoplasm to the nucleus
following microinjection (14). Moreover, U8 snoRNA associ-
ates with the import factor snurportin 1 in mammalian cells,
and knockdown of this transport adaptor is associated with
increased cytoplasmic U8 (11). Whether snurportin 1 serves a
broader role in transport of the overall class of snoRNAs and
whether other transport proteins function to regulate the dis-
tribution of snoRNAs between the nucleus and cytoplasm is not
known.
We identified nuclear export factor 3 (NXF3) through an
shRNA loss-of-function genetic screen in humanumbilical vein
endothelial cells to identify genes required for the cytotoxic
response to metabolic stress. Based on sequence similarity,
NXF3 is considered to be a member of a nuclear RNA export
factor family that includes the knownmRNA exporter, nuclear
export factor 1 (NXF1). Like other familymembers,NXF3 shut-
tles between the nucleus and cytoplasm and can associate with
and transport poly(A) RNA (15). Given that our genetic
screens implicated both snoRNAs and NXF3 in lipotoxic
response pathways, we hypothesized that NXF3 may also serve
as a transporter for snoRNAs. Herein, we demonstrate that
NXF3 regulates distribution of the Rpl13a snoRNAs between
the nucleus and the cytosol under homeostatic conditions.
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NXF3 associates with a broad array of boxC/D and boxH/ACA
snoRNAs, including the Rpl13a snoRNAs. Treatment of cells
with the adenylyl cyclase activator forskolin decreases cytosolic
snoRNAs through a mechanism that is dependent on NXF3
expression. Our data provide new insights into the molecular
regulation of snoRNA localization.
Results
Knockdown of NXF3 protects against lipotoxic cell death in
endothelial cells
To identify genes critical for the cell death response to lipo-
toxicity, we performed a genome-wide loss-of-function shRNA
screen in immortalized human umbilical vein endothelial cells
(HUVECs), which are sensitive to lipotoxicity. Cells were trans-
duced with seven pools of lentivirus, each containing 10,000
unique shRNAs targeting expressed human genes and a puro-
mycin selectable marker. As a control, cells were transduced in
parallel with a non-silencing shRNA virus that has no homo-
logy to knownmammalian genes. HUVECs that survived puro-
mycin selection were then treated for 48 h in media supple-
mentedwith pathophysiological levels of palmitic acid tomodel
lipotoxic conditions. Compared with cells transduced with the
non-silencing control shRNA, cells transduced with an shRNA
targeting NXF3 demonstrated less induction of markers of
endoplasmic reticulum stress, an early feature of the lipotoxic
response (Fig. 1A). Furthermore, cells with the NXF3-targeting
shRNA had improved viability under lipotoxic conditions (Fig.
1B). The shRNA targeting NXF3 led to a 72% decrease in NXF3
mRNA levels (Fig. 1C) and a 31% decrease in NXF3 protein
expression (Fig. 1D), consistent with knockdown of its gene
target in these lipotoxicity-sensitive human cells. NXF3 is a
member of the NXF family that includes the general mRNA
export receptor, NXF1. Our shRNA library included shRNAs
that target NXF1, but cells transduced with NXF1-targeting
shRNA or shRNA targeting other known RNA transporters did
not survive the palmitate selection. Together these observa-
tions implicate a critical role for NXF3, but not NXF1, in the
lipotoxic response pathway.
NXF3 knockdown endothelial cells have aberrant Rpl13a
snoRNA localization
Although NXF3 can associate with mRNAs, other potential
cargo such as non-coding RNAs has not been investigated (16).
Given the important role of Rpl13a snoRNAs U32a, U33,
U34, and U35a in lipotoxic and oxidative stress-induced cell
death and the observation that these snoRNAs accumulate in
the cytoplasm under metabolic stress conditions (8, 10), we
hypothesized that NXF3 knockdown might affect localization
of snoRNAs.We assessed Rpl13a snoRNA localization in cyto-
solic fractions of control- and NXF3-shRNA-transduced cells
by isolating cytosolic and non-cytosolic fractions using digito-
nin extraction. Under normal homeostatic growth conditions,
levels of cytosolic Rpl13a snoRNAs in NXF3 shRNA-trans-
duced cells were significantly increased compared with control
shRNA-transduced cells, even though total cellular abundance
for these snoRNAs was unchanged (Fig. 2A).Western blottings
demonstrated that both nuclear (nucleophosmin) and cytosolic
(HSP90, -tubulin) markers segregated as expected in both
control and NXF3 shRNA-transduced cells (Fig. 2B). Consist-
ent with prior observations in other cell types that oxidative
stress stimulates cytosolic accumulation ofRpl13a snoRNAs (8,
17), U32a,U33, andU34 snoRNAs accumulate in the cytoplasm
of control shRNA-transduced HUVECs in response to treat-
mentwith hydrogen peroxide (Fig. 2C). Hydrogen peroxide had
no detectable effect on localization of U35a, which is the least
abundant of the Rpl13a snoRNAs and shows less robust cyto-
solic accumulation in response to othermetabolic stress induc-
ers (8). In NXF3 shRNA-transduced cells, hydrogen peroxide
did not cause further increase in the cytoplasmic levels of
Rpl13a snoRNAs. Elevated cytoplasmic levels of the snoRNAs
under homeostatic conditions in NXF3 shRNA-transduced
cells are unlikely to be the result of increased basal oxidative
stress, because intracellular hydrogen peroxide levels as assessed
by dihydroethidium staining were unchanged compared with
control cells (Fig. 2D). Nucleophosmin staining showed preser-
vation of discrete nucleolar foci in NXF3 shRNA-transduced
cells, in contrast to the diffuse nucleophosmin staining charac-
teristic of nucleolar stress in hydrogen peroxide-treated cells
(Fig. 2E), indicating that NXF3 knockdown does not cause
nucleolar stress (18). Our findings that loss-of-function of
NXF3 perturbs Rpl13a snoRNA subcellular localization indi-
cates that NXF3 functions under homeostatic conditions to
maintain the distribution of these non-coding RNAs between
the nucleus and cytoplasm. Although NXF3 has been proposed
Figure 1. Knockdown of NXF3 protects against lipotoxic cell death in
endothelial cells. HUVECs were transduced with non-targeting (ctrl) or
NXF3-targeting shRNA.A,quantificationof ER stressmarkers (CHOP andATF4)
by RT-qPCR relative to Rplp0 (relative units, RU) following 4 h of incubation in
media containing 500 M palmitate. n 3 independent experiments. B, via-
bility following 48 h of incubation inmedia containing 500M palmitate. n
4. C, RT-qPCR quantification of NXF3 mRNA relative to Rplp0. n 3. D, repre-
sentative Western blot analysis of NXF3 and HSP90 expression (top panels)
and corresponding Ponceau-stained gel (bottom panel). Graphs report quan-
tification of NXF3 expression relative to HSP90 or total protein from n  3.
Means S.D. *, p 0.05; **, p 0.01 for NXF3 knockdown versus control.
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as anmRNAexport factor, accumulation ofRpl13a snoRNAs in
the cytosol in the setting of NXF3 knockdown implicates an
additional role for this protein in nuclear import of these small
non-coding RNAs.
NXF3 and NXF1 associate with snoRNAs
Because NXF3 is a member of a nuclear RNA transporter
family, and genetic manipulation of NXF3 impacted Rpl13a
snoRNA localization, we hypothesized that NXF3 may serve as
a snoRNA transporter. To further elucidate the effects of NXF3
on snoRNA localization, we used NIH3T3 murine fibroblasts
and H9c2 rat cardiomyoblasts, cell types that are also sensitive
to lipotoxocity but grow more rapidly in cell culture and trans-
fect with greater efficiency than HUVECs (8, 10, 19). To test
whether NXF3 physically interacts with the Rpl13a snoRNAs,
we transiently transfected NIH3T3 fibroblasts with NXF3-GFP
or GFP alone as a negative control. We also transfected cells
with NXF1-GFP, another NXF family member with related
domain structure (Fig. 3A). We performed immunoprecipita-
tions using a GFP antibody or non-immune IgG as a control.
Antibody directed against GFP efficiently and specifically
pulled down NXF3-GFP, NXF1-GFP, or GFP, whereas no
NXF3-GFP, NXF1-GFP, or GFP was recovered in control
immunoprecipitations (Fig. 3B). Real-time PCRquantification
revealed a 9–12-fold increase in Rpl13a snoRNA association
with immunoprecipitated NXF3-GFP compared with immu-
noprecipitated GFP (Fig. 3C). Unexpectedly, the Rpl13a snoR-
NAs also associated with NXF1-GFP. These data indicate that
under mild detergent conditions chosen to preserve RNA–
protein interactions, bothNXF3-GFP andNXF1-GFP associate
with the Rpl13a snoRNAs. This may reflect an ability of these
transporters to bind a broad range of RNA species.
WeusedRNA-sequencing to determinewhetherNXF3 asso-
ciates only with Rpl13a snoRNAs or with snoRNAs more
broadly. We collected RNA from cell lysates before immuno-
precipitation (input) and RNA from immunoprecipitates (pull-
down) of NIH3T3 murine fibroblasts transfected with NXF3-
GFP. Because most snoRNAs lack poly(A) tails and do not
efficiently prime with random hexamers, they are not well-rep-
resented in libraries prepared using approaches suitable for
larger RNAs (20). To achieve broad coverage of snoRNAs from
both input and pulldown samples, we size-selected RNAs from
30 to 375nucleotides, a range thatwould excludemostmiRNAs
and include most snoRNAs. Libraries were prepared using an
Illumina small RNA library preparation kit, sequenced, and
aligned to mm9 Refseq Transcripts. We focused our analyses
on the non-rRNA sequences, which accounted on average for
55% reads in both input and pulldown samples (Table 1).
Greater than 98%of non-rRNA reads in the input and pulldown
Figure2.NXF3knockdownaltersRpl13a snoRNA localizationunderbasal growth conditions inendothelial cells.HUVECswere transducedwith control
(ctrl) or NXF3-targeting shRNA. A, RT-qPCR quantification of Rpl13a snoRNAs (relative to Rplp0) in cytosolic (left graph) or total extracts (right graph). n 4. B,
representativeWestern blot analysis of cytosolic and non-cytosolic fractions for cytosolic (HSP90;-tubulin, TUB) and nuclear (nucleophosmin,NPM) markers.
C, cells were untreated or treatedwith 1mMH2O2 for 4 h. RT-qPCR quantification of Rpl13a snoRNAs in cytoplasm relative to Rplp0 and normalized to levels in
untreated control shRNA-transduced cells. n  3. D, quantification of superoxide in untreated control and NXF3-knockdown cells by DHE staining. n  3
independent experiments, each sample containing 104 cells. E, representative immunofluorescence staining for NPM in untreated and H2O2-treated cells.
Nuclei stained with DAPI. Scale bar, 50 M. Means  S.D. *, p  0.05 for NXF3 versus control shRNA-transduced cells; #, p  0.05 for H2O2-treated versus
-untreated; ns, non-significant.
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samples aligned to snoRNAs, as expected (Table 2). In addition
to theRpl13a snoRNAs, NXF3 pulldown recoveredmany other
snoRNAs (Table 3), most of which belonged to the box C/D
class of snoRNAs, known to be most abundant (21–23).
Approximately 6% of reads in both input and pulldown aligned
to box H/ACA snoRNAs. Because of the methods required to
capture snoRNA sequences in library preparation, it was not
possible to determine whether NXF3 specifically enriches for
snoRNAs over other classes of RNAs. Nonetheless, the lack of
significant enrichment of specific snoRNA species in pulldown
relative to input snoRNAs indicates that NXF3 broadly associ-
ates with this class of small RNAs and does not have specificity
for the Rpl13a snoRNAs or other particular species (Table 3).
To validate association ofNXF3with additional boxC/D and
boxH/ACAsnoRNAs and to testwhetherNXF1 also interacted
Figure 3. snoRNAs associate with NXF proteins. A, domain structures of NXF1 and NXF3 showing RNA-binding domain (RBD), four leucine-rich repeat
domain (4 LRR), sequence with similarity to nuclear transport factor 2 (NTF2-like (p15 binding)), ubiquitin-associated-like domain (UBA), nuclear localizing
sequence (NLS), nuclear export sequence (NES), and CRM1-binding region. B and C,NIH3T3 fibroblasts were transfectedwith control plasmid (GFP) or plasmid
encoding NXF3-GFP or NXF1-GFP. Immunoprecipitation with -GFP or rabbit IgG (control) was analyzed by Western blot analysis using -GFP (B). Co-
immunoprecipitating RNA was quantified by RT-qPCR for Rpl13a snoRNAs and selected box C/D and box H/ACA snoRNAs. Graphs (C) report enrichment in
NXF3-GFP- or NXF1-GFP-transfected cells over GFP-transfected cells. Means  S.D. for n  3. *, p  0.05 for NXF3-GFP- or NXF1-GFP-transfected versus
GFP-transfected.
Table 1













Input 1 12622611 36.56 42.81 6914155 54.78 49.32
Input 2 8494636 36.53 43.23 3561964 41.93 36.13
Input 3 15845764 36.57 42.99 7717165 48.70 42.95
Pulldown 1 3321562 36.63 43.40 1498556 45.12 38.85
Pulldown 2 19470767 36.55 42.52 12639529 64.92 59.51
Pulldown 3 13412207 36.55 42.45 6330452 47.20 43.59
Table 2
Distribution of non-ribosomal RNA reads
NS means not significant.
RNA Input Pull down Significance
% %
C/D snoRNA 92.45 0.93 91.92 1.69 NS
H/ACA snoRNA 6.26 0.79 6.98 1.50 NS
lncRNA 0.24 0.04 0.33 0.08 NS
miRNA 0.27 0.02 0.19 0.07 NS
mRNA 0.76 0.09 0.59 0.13 NS
Other 0.02 0.00 0.00 0.00 NS
NXF3 regulates localization of snoRNAs
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with these snoRNAs, we transfected NIH3T3 fibroblasts
with NXF3-GFP, NXF1-GFP, or GFP as control, immuno-
precipitated with antibody to GFP, and we performed RT-
qPCR on recovered RNA for abundant snoRNAs for which
stem-loop primers were successfully designed. Each of the
snoRNAs tested showed enrichment in NXF3-GFP pull-
down over GFP pulldown (Fig. 3B). Most of these snoRNAs
also associated with NXF1-GFP. Together, our data indicate
that both NXF3 and NXF1 are capable of associating with a
broad range of snoRNAs.
Knockdown and overexpression of NXF3 alters cytosolic
Rpl13a snoRNAs in cardiomyoblasts
Although both NXF3 and NXF1 can associate with snoR-
NAs, only NXF3 conferred enhanced viability in our lipotoxic-
ity screen in HUVECs. To compare the effects of NXF3 and
NXF1 on snoRNA localization, we transfected H9c2 rat car-
diomyoblasts with siRNAs to knock down either NXF3 or
NXF1. Compared with control non-targeting siRNA, two inde-
pendent siRNAs directed against NXF3 led to a 93 and 84%
decrease in NXF3 mRNA levels, respectively, in cardiomyo-
blasts. NXF3 siRNAs were specific and did not significantly
change levels of family member NXF1 (Fig. 4A, left graph). We
found that commercially available antibodies directed against
rodent NXF3 are not specific for this family member (data not
shown), and our attempts to generate a specific antibody that
recognizes the rat or murine protein were unsuccessful, thus
precluding confirmation of the extent of knockdown of the
endogenous NXF3 protein. Nonetheless, knockdown of NXF3
mRNA led to a 50–100% increase in cytosolic levels of the
Rpl13a snoRNAs (Fig. 4A, right graph) without perturbing effi-
ciency of fractionation (Fig. 4B). In contrast, siRNAknockdown
of NXF1 had no effect on cytosolic levels of Rpl13a snoRNAs
(Fig. 4,C andD). Thus, accumulation ofRpl13a snoRNAs in the
cytosol can result from either acute or chronic knockdown of
NXF3. This effect is consistent across different cell types (endo-
thelial cells and cardiomyoblasts) and is not observed with
knockdown of NXF1.
Our data are consistent with a model in which NXF3 func-
tion is required to maintain low cytoplasmic levels of the
Table 3
Most abundant immunoprecipitating snoRNAs
FDR means false discovery rate, and NS means not significant.
Gene ID
LS mean
(pull down) LS mean (input)
Enrichment
(pull down/input) FDR p value Significance
Snord55 421533.33 422930.00 1.00 1.00 0.84 NS
Snord44 299548.00 218320.33 1.37 0.99 0.87 NS
Z23 229492.67 218334.00 1.05 0.99 0.56 NS
Snord24 208143.67 156536.67 1.33 0.99 0.90 NS
Snord2 144321.67 150285.33 0.96 1.00 0.64 NS
Snora48 120987.00 114743.00 1.05 0.99 0.87 NS
Snord45 97189.00 82084.33 1.18 0.99 0.77 NS
Z19 76795.67 86895.67 0.88 0.99 0.57 NS
Z15 70041.33 78718.67 0.89 0.99 0.64 NS
Snord14e 56763.00 51011.67 1.11 0.99 0.90 NS
Snord4a 50187.00 32887.00 1.53 1.00 0.91 NS
Snord96a 29898.00 36448.00 0.82 1.00 0.53 NS
Snord45c 26526.00 17509.67 1.51 0.99 0.99 NS
Snord74 23828.33 20331.67 1.17 0.99 0.74 NS
Snord32a 23639.33 36071.67 0.66 1.00 0.62 NS
Snord14d 18182.33 14849.67 1.22 0.99 0.79 NS
Snord14c 14650.00 11996.67 1.22 0.99 0.77 NS
Snord73 11345.33 10193.33 1.11 0.99 0.61 NS
Snord34 10821.67 9770.33 1.11 1.00 0.61 NS
Snord95 9882.33 7793.67 1.27 1.00 0.84 NS
Snord1b 8164.00 8715.67 0.94 1.00 0.49 NS
Snord35a 5050.33 7777.33 0.65 1.00 0.43 NS
Snord113 4508.67 5383.67 0.84 0.99 0.81 NS
Snord82 4491.33 3655.33 1.23 1.00 0.97 NS
Snord104 3567.00 2764.67 1.29 1.00 0.98 NS
DQ267100 2406.67 3323.33 0.72 0.99 0.50 NS
Snord100 2392.67 2097.33 1.14 1.00 0.76 NS
Snord1c 2302.00 2378.67 0.97 1.00 0.42 NS
Snord12 2044.33 862.67 2.37 1.00 0.34 NS
Snord33 1497.33 881.00 1.7 1.00 0.87 NS
Snord15b 1280.00 1128.67 1.13 1.00 0.99 NS
Snord123 1268.67 1322.00 0.96 1.00 0.45 NS
Rnu73b 980.33 984.00 1.00 1.00 0.47 NS
DQ267102 963.33 1123.33 0.86 0.99 0.74 NS
Snord92 746.67 466.00 1.60 1.00 0.88 NS
Snord37 650.00 674.67 0.96 0.99 0.61 NS
AF357426 647.33 366.67 1.77 0.99 0.98 NS
AF357425 505.67 525.67 0.96 0.99 0.81 NS
Snord15a 478.00 545.67 0.88 1.00 0.69 NS
AF357355 317.33 388.00 0.82 0.99 0.87 NS
Snord110 297.33 158.00 1.88 1.00 0.62 NS
Snora24 271.51 742.24 0.37 1.00 0.07 NS
Z21 220.00 144.67 1.52 0.99 0.93 NS
Gm24148 198.00 134.00 1.48 1.00 0.78 NS
Snord22 189.33 340.00 0.56 1.00 0.24 NS
Snora52 180.00 212.67 0.85 1.00 0.42 NS
Snora16a 163.33 144.00 1.13 1.00 0.75 NS
NXF3 regulates localization of snoRNAs
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Rpl13a snoRNAs. To test whether NXF3 promotes movement
of snoRNAsbetween the cytosol andnucleus, we overexpressed
murine NXF3 by transiently transfecting NIH3T3 murine
fibroblasts with a GFP-tagged NXF3 construct (NXF3-GFP),
a GFP-tagged NXF1 construct (NXF1-GFP), or a plasmid
expressing GFP alone as control. We consistently observed
more efficient transfection with GFP (76%) compared with
NXF3-GFP (46%) or NXF1-GFP (40%), suggesting that endog-
enous mechanisms serve to restrict the overall expression of
NXF3 andNXF1 (Fig. 5A). Nonetheless, comparedwith expres-
sion of GFP alone, expression of NXF3-GFP decreased cytoso-
lic levels of the Rpl13a snoRNAs by 16–34%, whereas NXF1-
GFP did not significantly change cytosolic levels (Fig. 5, B and
C). Together with findings from knockdown of NXF3, our data
suggest a model in which NXF3 specifically promotes move-
ment of snoRNAs from the cytoplasm to the nucleus and deter-
mines the distribution of the snoRNAs between these cellular
compartments.
Regulation of snoRNA trafficking and association with NXF3
Nucleocytoplasmic transport can serve as a point of regula-
tion of subcellular localization for proteins aswell as RNAs (24).
Cyclic AMP is a potent regulator of protein trafficking, but it is
not known whether this second messenger impacts NXF3 or
snoRNA localization. We found that treatment of fibroblasts
for 1 hwith forskolin (FSK), an adenylyl cyclase activator, which
increases cyclic AMP levels, significantly decreased cytosolic
Rpl13a snoRNA levels compared with DMSO-treated controls
(Fig. 6,A and B). To test whether FSK affects NXF3 localization
or its associationwith snoRNAs,we transfected fibroblastswith
a plasmid for expression of NXF3-GFP or NXF1-GFP. Similar
to our findings with untransfected cells, cells overexpressing
NXF3-GFP or NXF1-GFP had decreased cytosolic snoRNA
abundance following 1 h of treatment with FSK (Fig. 6, C–F).
Moreover, FSK increased association of NXF3-GFP with the
Rpl13a snoRNAs (Fig. 7A). Concomitantly, immunofluores-
cence microscopy revealed increased nuclear localization of
NXF3-GFP (Fig. 7B). By contrast FSK did not affect snoRNA
association with NXF1-GFP or the cellular distribution of
NXF1-GFP, which is predominantly nuclear (Fig. 7, C and D).
Together, these observations are consistent with a model of
NXF3-mediated trafficking of snoRNAs from the nucleus to the
cytoplasm that is regulated by FSK. Moreover, these findings
lend further specificity to the function of NXF3 in snoRNA
trafficking.
To establish whether the FSK-induced changes in localiza-
tion of Rpl13a snoRNAs are dependent on NXF3, cardiomyo-
blasts were transiently transfected with siRNA to knock down
NXF3 (Fig. 8A) and then treated with FSK. Although FSK
decreased cytosolic Rpl13a snoRNAs as expected in control
siRNA-transfected cells, this effect was abrogated when NXF3
was knocked downwith either of two independent siRNAs (Fig.
8B). In contrast, NXF1 siRNA knockdown had no effect on the
FSK-snoRNAphenotype (Fig. 8B). Taken together, our data are
most consistent with a model in which NXF3 plays a critical
role in return of snoRNAs from the cytoplasm to the nucleus, a
pathway that can be activated by FSK.
Discussion
The endogenous substrates for NXF3, a member of a family
of RNA transport proteins, are not well-characterized. Addi-
tionally, relatively little is known regarding the regulation of
distribution of snoRNAs between the nucleus and cytoplasm.
Herein, we demonstrate that gain- and loss-of-function of
Figure4.KnockdownofNXF3,butnotNXF1, altersRpl13a snoRNA localization.H9c2cardiomyoblastswere transfectedwith scrambled siRNA (ctrl) or two
independent siRNAs targeting NXF3 (A and B) or siRNAs targeting NXF1 (C andD). RT-qPCR quantification of NXF3 and NXF1 in total RNA (A and C, left graphs)
and Rpl13a snoRNAs in cytosolic RNA (A andC, right graphs) forn 3. RepresentativeWestern blot analysis (B andD) of cytosolic andnon-cytosolic fractions for
cytosolic (HSP90 and TUB) and nuclear (NPM)markers as controls forA andC, respectively.Means S.D. *, p 0.05 for NXF3 orNXF1 knockdown versus control.
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NXF3 alters subcellular distribution of snoRNAs encoded
within the Rpl13a locus. Furthermore, we show that NXF3
associates with many box C/D and box H/ACA snoRNAs and
regulates distribution of these small non-coding RNAs as a
class. Our data aremost consistentwith amodel inwhich snoR-
NAs cycle between the nucleus and cytoplasm and NXF3 effi-
ciently imports snoRNAs from the cytoplasm to the nucleus, a
function that helps to maintain low levels of snoRNAs in the
cytoplasm under basal conditions (Fig. 9). Furthermore, we
show that regulation of snoRNA distribution by FSK requires
NXF3.
NXF family members have been identified based on sequence
similarity and domain architecture that for most includes an
amino-terminal containing RNA-binding protein interaction
domain, a p15/NXT-heterodimerization domain, and a car-
boxyl-terminal domain involved in nuclear pore binding (25,
26). NXF1, NXF2, NXF3, and NXF5 have been shown to func-
tion in nuclear export of mRNAs, whereas NXF7 has been pro-
posed to function in the cytoplasmic trafficking of mRNAs (15,
27–31). NXF3, which lacks carboxyl-terminal domains that
function in nuclear export and nucleoporin binding, has a
CRM1-dependent nuclear export sequence that allows it to
partner with this transport receptor for its mRNA export func-
tion (15). Our study provides evidence that NXF3, but not
NXF1, is also involved in transporting snoRNA cargos, expand-
ing the functional repertoire of NXF proteins. Moreover, our
data support a model in which NXF3 has a role in returning
snoRNAs to the nucleus. Functional domains ofNXF3 required
for nuclear export of mRNA have been characterized (15, 26).
However, nuclear localization sequences can be highly variable,
and examination of the NXF3 sequence did not reveal motifs
predicted with high likelihood to function in nuclear import,
raising the possibility that NXF3 could function in a complex
with other proteins. Our data provide evidence of a role for
NXF3 in snoRNA transport. However, interaction of NXF3
with snoRNAs could be direct or indirect. In contrast to other
NXF family members, RNA-binding domains of NXF3 are pre-
Figure 5. Overexpression of NXF3, but not NXF1, alters Rpl13a snoRNA localization in fibroblasts. NIH3T3 fibroblasts were transfected with control
plasmid (GFP) or plasmids encoding NXF3-GFP or NXF1-GFP. A, flow cytometric analysis of transfected cells. n 3. B, RT-qPCR of cytosolic Rpl13a snoRNAs for
n 3. C, representative Western blot analysis of cytosolic and non-cytosolic fractions for cytosolic (HSP90 and TUB) and nuclear (NPM) markers. Means S.D.
*, p 0.05 for NXF3 knockdown versus control.
Figure 6. Forskolin decreases Rpl13a snoRNAs in cytoplasm. A, C, and E,
untransfectedNIH3T3 fibroblasts (A), cells transfectedwithNXF3-GFP (C), and
cells transfected with NXF1-GFP (E) were treated with 10 M FSK or vehicle
(DMSO) for 1 h. Quantification of cytosolic snoRNAs relative to Rplp0.
Means S.D. for n 3. *, p 0.05 for FSK versusDMSO. B, D, and F, represen-
tative Western blot analysis of cytosolic and non-cytosolic fractions for cyto-
solic (HSP90 and TUB) and nuclear (NPM) markers for experiments in untrans-
fected (B), NXF3-GFP-transfected (D), and NXF1-GFP-transfected (F) cells.
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dicted but have not been functionally confirmed (32). In future
studies, experimental delineation of RNA-binding residues in
NXF3 will facilitate structure–function studies to determine
whether this protein interacts directly with snoRNAs. In addi-
tion, future development of an in vitro nuclear transport assay
for snoRNAs will help to test our model.
Figure 7. Forskolin increases NXF3-GFP-snoRNA association. A and B, NIH3T3 fibroblasts were transfected with plasmid encoding NXF3-GFP (A) or NXF1-
GFP (B). Following treatment with FSK or vehicle (DMSO) for 1 h, Rpl13a snoRNAs immunoprecipitated with -GFP were quantified by qPCR. C and D,
representative immunofluorescencemicrographs ofNXF3-GFP-transfected (C) or NXF1-GFP-transfected (D) cells following 1hof treatmentwith FSKor vehicle
(DMSO).Graphs report the relative nuclear localization quantified from n 3 independent experiments. Scale bar, 50M.Means S.D. for n 3. *, p 0.05 for
FSK versus DMSO.
Figure 8. Forskolin effect on snoRNA localization is dependent on NXF3. H9c2 cardiomyoblasts were transfected with scrambled siRNA (ctrl) or two
independent siRNAs targeting NXF3 or siRNA targeting NXF1 and subsequently treated for 1 hwith 10M FSK or vehicle (DMSO). A, RT-qPCR quantification of
total NXF3 andNXF1 relative to Rplp0. B, RT-qPCRquantification of cytosolic Rpl13a snoRNAs relative to Rplp0.Means S.D. for n 3. *, p 0.05 for FSK versus
DMSO.
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Following transcription, snoRNAs that are processed from
the introns of pre-mRNA or that are generated from indepen-
dently transcribed units first move to Cajal bodies, where they
assemble in tomature snoRNPs, and subsequently to the nucle-
olus, where they encounter nascent rRNA substrates. PHAX, a
known adaptor for RNA export, is required for movement
to the Cajal body, and CRM1, a nuclear export receptor, is
required formovement to the nucleolus (33). A growing body of
evidence indicates that snoRNAs traffic to the cytoplasm and
extracellular space (8, 10–13, 34). Whether snoRNAs undergo
processing in the cytoplasm analogous to snRNAs, function
outside the nucleus, or are secreted in a regulated fashion
remains to be determined. Nonetheless, cells maintain a gradi-
ent of snoRNAs such that the vast majority of endogenously
expressed snoRNAs remain localized within the nucleus, and
when exogenous snoRNAs are introduced into the cytoplasm,
they are trafficked into the nucleus through the nuclear pore
complex (14, 35). To date, PHAX and Snurportin 1 have been
shown to function in nucleocytoplasmic trafficking of U8, an
independently transcribed, capped box C/D snoRNA (11), but
it is not known whether these proteins regulate the cytosolic
trafficking of other snoRNAs.Our study provides the first dem-
onstration of a transport protein that regulates cytoplasmic
localization of snoRNAs as a class, including both box C/D and
box H/ACA species, and it is likely functioning to return
cytoplasmic snoRNAs to the nucleus. Inhibition of CRM1
function with leptomycin B decreased, rather than increased,
cytosolic snoRNA abundance,3 suggesting that in contrast to
themRNA export function of NXF3, NXF3-mediated return of
snoRNAs to the nucleus may be independent of this transport
co-receptor.
Transport of RNAs between the nucleus and cytoplasm is a
highly regulated process, and our studies provide new evidence
that FSK regulates the association of snoRNAs and the trans-
port protein, NXF3, as well as the trafficking of both snoRNAs
and NXF3. Although it is possible that FSK-induced transloca-
tion of NXF3 leads to increased association with snoRNAs that
are concentrated in the nucleus, our data establish that NXF3 is
required for acute regulation of nuclear snoRNA import by
FSK. FSK is a natural compound that activates cyclic AMP sig-
naling through both PKA-dependent and PKA-independent
mechanisms (36–39). This could lead to altered post-transla-
tionalmodifications, such as phosphorylation ofNXF3 or other
proteins that function in snoRNA transport. Although exami-
nation of the NXF3 primary sequence suggests a number of
potentialphosphorylationsites,FSKdidnotchangeNXF3phos-
phorylation, as determined using a panel of-phosphotyrosine,
-phosphoserine, and -phosphothreonine antibodies.3 It is
possible that the available antibodies lack the appropriate spec-
ificity or that NXF3 is not a direct target of FSK. Future
structure–function and mass spectrometry studies will be nec-
essary to address these possibilities.
KnockdownofNXF3 confers resistance to lipotoxicity, a pro-
cess dependent on snoRNAs from theRpl13a locus. These non-
codingRNAs accumulate in the cytoplasmearly during lipotox-
icity (10, 17, 19). Loss of NXF3 also alters distribution of these
snoRNAs at baseline and prevents the acute increase in cytoso-
lic levels with lipotoxicity. The abundance of cytoplasmic
Rpl13a snoRNAs inNXF3-knockdown cells is comparablewith
the levels achieved in control cells following acute lipotoxic
exposure. This suggests that the dynamic change in cytosolic
snoRNAs, rather than the absolute cytoplasmic levels of these
non-coding RNAs, is a key contributor to lipotoxic injury.
Recent genetic studies and identification of diseases associ-
ated with dysregulation of snoRNAs have expanded the biolog-
ical repertoire for snoRNAs beyond their well-appreciated
canonical role in modification of nascent rRNAs (9, 40, 41).
Although it is certainly possible that dynamic changes in
snoRNA-directed rRNA modifications contribute to these
intriguing phenotypes, localization of snoRNAs in the cyto-
plasm also raises the possibility that non-canonical snoRNA
functions aremediated through effects on novel targets outside
the nucleolus. A complete understanding of this new snoRNA
biology requires further dissection of snoRNA trafficking and
its regulation. Our identification of a role forNXF3 in regulated




Digitonin, FSK, phenylmethanesulfonyl fluoride (PMSF),
and dimethyl sulfoxide (DMSO) were from Sigma. Protein A
Dynabeads and TURBO DNase were from Thermo Fisher
Scientific. Doxorubicin (DOX) was from Cayman Chemical.
TRIzol LS and SUPERase-IN RNase inhibitor was from Life
Technologies, Inc. DTT was from Calbiochem, and -mer-
captoethanol was from Sigma. Laemmli Sample Buffer was
from Bio-Rad.
Plasmids
The NXF3 cDNA was obtained from the Sun lab (42) and
cloned into pEGFP-C1 (Clontech) at BamHI and SalI sites. The
full-length cDNA for mouse NXF1 was obtained by PCR from
the total RNA of NIH3T3mouse fibroblasts using primers con-
taining BamHI and SalI restrictions sites. NXF1 cDNA was3 M. W. Li, and J. E. Schaffer, unpublished data.
Figure 9. Model for NXF3 function in snoRNA localization. snoRNAs cycle
between the nucleus and cytoplasm under homeostatic conditions. NXF3
functions as an importer, efficiently returning snoRNAs to the nucleus to
maintain low snoRNA abundance in the cytoplasm relative to the nucleus.
FSK treatment enhances return of NXF3–snoRNA complexes to the nucleus,
further depleting cytosolic levels of snoRNAs.
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cloned into pEGFP-C1 (Clontech) at BamHI and SalI sites.
PCR-derived sequences were confirmed by DNA sequencing.
Cells
H9c2 cardiomyoblasts and NIH3T3 fibroblasts were from
American Type Culture Collection. Telomerase-immortalized
HUVECswere a gift from Judah Folkman’s laboratory (Harvard
Medical School) (43), and H9c2 and 3T3 cells were maintained
in Dulbecco’s modified Eagle’s medium (DMEM) with 10%
heat-inactivated fetal bovine serum (H9c2) or 10% calf serum
(NIH3T3). HUVECs were maintained in endothelial cell
growth medium (Lonza). DOX (20 M for 1 h), FSK (10 M for
1 h), H2O2 (1 mM, 4 h), or palmitate (500 M) was added to
media as indicated. Cell viability was determined using
CellTiter-Glo Luminescent Cell Viability Assay (Promega).
Basal cellular ROS was detected by staining cells (100,000 cells
per well of 12-well dishes) with 10 M dihydroethidium (DHE)
(Thermo Fisher Scientific) and detection using a microplate
fluorescence reader (Tecan). ROS after palmitate treatment
was detected by staining cells (200,000 cells per well of 6-cm
dishes) with CellROX Deep Red Reagent (5 M, 30 min)
(Thermo Fisher Scientific) and detection using flow cytometric
analysis on 104 cells/sample. Cells were transfected with plas-
mid DNA peGFP-1, NXF3-GFP, and NXF1-GFP using Lipo-
fectamine 2000 (Life Technologies, Inc.) and with siRNAs
(Life Technologies, Inc., Silencer Select) using RNAiMax
(Life Technologies, Inc.), according to the manufacturers’
protocols. Flow cytometric analysis of transfected cells
assessed fluorescence on 104 cells/sample.
shRNA screen
The shRNAscreenwas performedusingDecode Pooled Len-
tiviral shRNALibraries by Thermo Fisher Scientific. Immortal-
izedHUVECswere transducedwith lentiviral shRNApools at a
multiplicity of infection of 0.1 and then selected using puromy-
cin. Puromycin-resistant cells were then treated with 500 M
palmitate for 48 h. After removing palmitate, cells were grown
to form colonies in normal media. Colonies were hand-picked
and re-tested for viability following lipotoxic exposure. For this,
cells were plated in a 96-well plate in triplicate (1000 cells per
well) and treated with 500 M palmitate for 24 h. Cells trans-
duced with non-targeting shRNA viral particles (designed to
not target mRNAs in the mammalian genome) were used as
negative control. Colonies with significantly greater viability
than control cells were selected for further analysis. Genomic
DNA was isolated from palmitate-resistant cells, and PCR
was used to amplify barcodes corresponding to specific shR-
NAs for sequencing. Sequences were compared with the
Decode shRNA libraries or analyzed using BLAST to identify
the knocked down genes.
Subcellular fractionation
For fractionation by detergent extraction, cell pellets were
incubated in digitonin buffer (150 mM NaCl, 50 mM HEPES,
pH 7.4, 100 g/ml digitonin, 5 mM EDTA, and 0.1 unit/l
SUPERase-In RNase inhibitor) for 10 min and centrifuged for
10 min at 2000  g to yield a cytoplasmic supernatant and
non-cytoplasmic pellet containing membranes and nuclei (44).
RNA isolation and quantitative real-time PCR
Total RNA was isolated from cytoplasmic or non-cytoplas-
mic fractions and from immunoprecipitates using TRIzol LS
according to manufacturer’s protocol (Life Technologies, Inc.).
cDNAwas synthesizedwith SuperScript III first-strand synthe-
sis system (Invitrogen) using oligo(dT) priming formRNAs and
target-specific stem-loop priming snoRNAs (10). qPCR was
performed using PerfeCTa SYBR Green SuperMix (Quanta-
bio). Relative quantitation of target transcript expression was
calculated using the ddCT method using Rplp0 as an endoge-
nous control on an ABI 7500 fast real-time PCR system.
Immunoprecipitation
Cells were sonicated in 50 mM Tris, pH 8.0, 150 mM NaCl, 2
mM EDTA, 0.5% Nonidet P-40 containing 1 cOmplete prote-
ase inhibitor mixture (Sigma), 1 mM PMSF, and 0.1 unit/l
RNase inhibitor SUPERase-In. After treatment with 0.3 units/l
TURBODNase, insoluble material was removed by centrifuga-
tion at 20,000 g for 10 min at 4 °C. Lysate was incubated with
-GFP (2.5 mg/ml) and protein A Dynabeads for 4 h at 4 °C.
Complexes were washed four times with lysis buffer. ForWest-
ern blot analysis, protein was eluted by incubation in Laemmli
Sample Buffer, and RNAwas eluted by incubation in TRIzol LS.
RNA sequencing
Input and immunoprecipitated RNA from three indepen-
dent experiments was isolated and concentrated using RNA
Clean and Concentrator-5 (Zymo Research). Indexed RNA-se-
quencing libraries were made using the Illumina TruSeq small
RNA kit. Libraries were amplified with 14 cycles of PCR,
pooled, and separated by PAGE. Products with sizes 30–375
nucleotides were excised and collected from the gel. Sequenc-
ing was performed using an Illumina HiSeq 2500. Demulti-
plexed data were analyzed using Partek Flow (build version
6.0.17.0305 Copyright ©; 2017 Partek Inc., St. Louis, MO).
Sequences were evaluated for quality and trimmed to
remove adaptor sequence. A custom Linux script was used
to remove murine ribosomal sequences according to the
Illumina iGenome murine genome annotation. Remaining
sequences were aligned to the murine genome (mm9 Refseq
Transcript August 1, 2016, Bowtie for Illumina, default set-
tings), and aligned reads were quantified, normalized, and
annotated. Analysis was limited to genes with 	100 aligned
reads. A step-up false discovery rate of 0.05 was considered
significant. Sequence data have been deposited in NCBI’s Gene
Expression Omnibus (accession number GSE106301).
Immunoblots
Protein in total, cytoplasmic, and non-cytoplasmic fractions
was quantified by bicinchoninic assay (Thermo Fisher Scien-
tific), separated by SDS-PAGE, and immunoblotted. Detection
for human nuclear export factor 3 (NXF3; Abcam ab76430,
1:500), GFP (Abcam ab290, 1:5000), heat-shock protein 90
(HSP90; Enzo SPA-846, 1:1000), -tubulin (Sigma T6199,
1:2000), and nucleophosmin (NPM; Abcam ab37659, 1:1500) used
horseradishperoxidase-conjugated secondaryantibodies (Jackson
ImmunoResearch) and Western Lightning Plus-ECL (Perkin-
Elmer Life Sciences) using a ChemiDoc Imaging System.
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Cells were grown on glass coverslips coated with 0.8% gela-
tin, fixed with 4% paraformaldehyde, permeabilized with Non-
idet P-40, and blocked with 200 g/ml ChromPure IgG (Jack-
son ImmunoResearch) corresponding to secondary antibody
species. Detection for NPM used -NPM (Life Technologies,
Inc., 325200; 1:1000) with secondary Alexa Fluor 350 donkey
anti-mouse IgG (Life Technologies, Inc., A10035; 40 g/ml).
GFP transfected cells were grown on glass coverslips and
fixed with 4% paraformaldehyde. Coverslips were mounted
on microscope slides using SlowFade Antifade reagent (Life
Technologies, Inc., S2828). Slides were imaged on a Zeiss
Axioskop 2 mot plus microscope with a Zeiss AxioCam
MRm camera with a 40 oil immersion objective at room
temperature. Images were acquired using AxioVision Rel.
4.8 software. Images were processed identically using the
ImageJ software package.
Statistics
Biochemical results are presented as mean S.D. for a min-
imum of three independent experiments. Statistical signifi-
cance was assessed by two-tailed unpaired t test. p value 0.05
was considered significant.
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